linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Wockhardt Ltd.
 
Source DateBoard Meeting DateDetails
28 Apr 202604 May 2026 Audited Results Inter alia, to consider and approve:- (i) raising of funds by issue of Equity Shares, Equity Shares through depository receipt including Global Depository Receipts , American Depository Receipts , Foreign Currency Convertible Bonds , Fully Convertible Debentures , Partly Convertible Debentures OCD, and /or NCD and/ or other securities convertible into Equity Shares with or without warrants and/ or convertible preference shares or any security convertible into Equity Shares, or any combination of such securities in one or more tranches by way of one or more public and/ or private offerings including QIP and/or on preferential allotment basis or any combination thereof or any other method as may be permitted.
04 Feb 202610 Feb 2026 Quarterly Results
29 Oct 202503 Nov 2025 Quarterly Results
01 Aug 202508 Aug 2025 Quarterly Results
23 May 202529 May 2025 Audited Results
03 Feb 202507 Feb 2025 Quarterly Results
08 Nov 202413 Nov 2024 Quarterly Results
05 Aug 202409 Aug 2024 Quarterly Results
21 May 202428 May 2024 Audited Results
20 Mar 202426 Mar 2024 Inter alia, to consider and determine the issue price of Equity Shares to be issued pursuant to the Issue, including any discount, not more than 5%, on the floor price calculated in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (?SEBI ICDR Regulations?) and approved by the shareholders of the Company pursuant to a special resolution dated 14th August, 2023.
05 Feb 202414 Feb 2024 Quarterly Results
06 Nov 202314 Nov 2023 Quarterly Results
04 Aug 202314 Aug 2023 Quarterly Results
19 May 202326 May 2023 Audited Results
03 Feb 202313 Feb 2023 Quarterly Results
28 Oct 202204 Nov 2022 Quarterly Results
04 Aug 202212 Aug 2022 Quarterly Results
23 May 202230 May 2022 Audited Results
28 Feb 202203 Mar 2022 Rights Issue
20 Jan 202227 Jan 2022 Quarterly Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.